smifs

SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE438.654.85 (+1.12 %)
PREV CLOSE ( ) 433.80
OPEN PRICE ( ) 436.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 438.65 (258)
VOLUME 328914
TODAY'S LOW / HIGH ( )425.80 441.90
52 WK LOW / HIGH ( )350.4 484.1
NSE439.255.1 (+1.17 %)
PREV CLOSE( ) 434.15
OPEN PRICE ( ) 437.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 439.25 (9059)
VOLUME 5386394
TODAY'S LOW / HIGH( ) 425.60 441.90
52 WK LOW / HIGH ( )344.55 484.25
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-03 1993
Management Info
Israel Makov - Chairman Dilip S Shanghvi - Managing Director
Registered Office

Address Sun Pharma Advanced Research Centre (S P A R C),Tandalja,,
Vadodara,
Gujarat-390020

Phone 0265- 5515500 / 5515600 / 5515700

Email secretarial@sunpharma.com

Website www.sunpharma.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
03Dec Sun Pharma gets partial relief from US
Sun Pharmaceutical Industries has received partial relief from a US cour..
02Dec Sun Pharmaceutical Industries informs
Sun Pharmaceutical Industries has informed that the Company along with i..
02Dec Sun Pharmaceutical Industries informs
Sun Pharmaceutical Industries has informed about disclosure under Regula..
02Dec In Re
Ranbaxy Generic Drug Application Antitrust Litigation in the US. Thanks
08Nov Lumax Industries, Infosys and Reliance
Lumax Industries has issued Commercial Paper (CP) amounting to Rs 50 cro..
Financials
Rs. in Millions
QTR Sep 19 ANNUAL 19
Net Profit8231.68166
Gross Profit 8396.3 7194.5
Operating Profit 10932.430277
Net Sales 33732.9103032.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 12973.85 (1.19%)
M.Cap ( in Cr)27568.53
Sanofi India (BSE)
 6974.00 (0.92%)
M.Cap ( in Cr)16061.56
Astrazeneca Pharma I (BSE)
 2819.40 (2.26%)
M.Cap ( in Cr)7048.50
Pfizer (BSE)
 4333.10 (1.20%)
M.Cap ( in Cr)19822.95
Glaxosmithkline Phar (BSE)
 1672.55 (1.63%)
M.Cap ( in Cr)28334.01
Shareholding Pattern
PROMOTERS 54.55%
NON-INSTITUTION 12.23%
MUTUAL FUNDS/UTI 10.34%
FI/BANKS/INSURANCE 7.95%
GOVERNMENT 0%
FII 0%